Northwest Biotherapeutics Inc (NWBO)
0.4659
+0.01
(+1.29%)
USD |
OTCM |
May 02, 16:19
Northwest Biotherapeutics Cash from Operations (Quarterly): -16.96M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.96M |
| September 30, 2023 | -13.92M |
| June 30, 2023 | -11.52M |
| March 31, 2023 | -11.24M |
| December 31, 2022 | -8.849M |
| September 30, 2022 | -16.12M |
| June 30, 2022 | -14.84M |
| March 31, 2022 | -12.97M |
| December 31, 2021 | -11.25M |
| September 30, 2021 | -7.013M |
| June 30, 2021 | -6.792M |
| March 31, 2021 | -13.25M |
| December 31, 2020 | -10.20M |
| September 30, 2020 | -8.022M |
| June 30, 2020 | -6.329M |
| March 31, 2020 | -7.539M |
| December 31, 2019 | -5.978M |
| September 30, 2019 | -6.452M |
| June 30, 2019 | -9.678M |
| March 31, 2019 | -9.751M |
| December 31, 2018 | -14.18M |
| September 30, 2018 | -4.053M |
| June 30, 2018 | -11.57M |
| March 31, 2018 | -4.787M |
| December 31, 2017 | -14.79M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.725M |
| June 30, 2017 | -3.693M |
| March 31, 2017 | -12.28M |
| December 31, 2016 | -14.10M |
| September 30, 2016 | -9.754M |
| June 30, 2016 | -14.21M |
| March 31, 2016 | -17.60M |
| December 31, 2015 | -23.23M |
| September 30, 2015 | -11.80M |
| June 30, 2015 | -27.10M |
| March 31, 2015 | -17.58M |
| December 31, 2014 | -18.60M |
| September 30, 2014 | -8.482M |
| June 30, 2014 | -16.94M |
| March 31, 2014 | -10.56M |
| December 31, 2013 | -14.60M |
| September 30, 2013 | -7.916M |
| June 30, 2013 | -8.209M |
| March 31, 2013 | -7.074M |
| December 31, 2012 | -8.249M |
| September 30, 2012 | -6.131M |
| June 30, 2012 | -4.833M |
| March 31, 2012 | -3.541M |
| December 31, 2011 | -4.555M |
| September 30, 2011 | -5.111M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.96M
Minimum
Dec 2023
-5.978M
Maximum
Dec 2019
-10.47M
Average
-10.20M
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.314M |
| Palatin Technologies Inc | -10.48M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.541M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.418M |
| Cash from Financing (Quarterly) | 14.42M |
| Free Cash Flow | -57.07M |
| Free Cash Flow Per Share (Quarterly) | -0.015 |
| Free Cash Flow to Equity (Quarterly) | -25.23M |
| Free Cash Flow Yield | -10.95% |